
James K. McCord MD
Adult Congenital Heart Disease
Assistant Professor, Internal Medicine, Wayne State University School of Medicine
Join to View Full Profile
Henry Ford Health System2799 West Grand BoulevardDetroit, MI 48202
Phone+1 313-916-2436
Fax+1 313-916-8907
Dr. McCord is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1988 - 1991
- The University of Toledo College of MedicineClass of 1988
Certifications & Licensure
- MI State Medical License 1991 - 2025
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Sex-specific high-sensitivity troponin T cut-points have similar safety but lower efficacy than overall cut-points in a multisite U.S. cohort.Connor M Montgomery, Nicklaus P Ashburn, Anna C Snavely, Brandon Allen, Robert Christenson
Academic Emergency Medicine. 2025-01-01 - 2 citationsRapid Acute Coronary Syndrome Evaluation Over One Hour With High-Sensitivity Cardiac Troponin I: A United States-Based Stepped-Wedge, Randomized Trial.Joseph Miller, Bernard Cook, Chaun Gandolfo, Nicholas L Mills, Simon Mahler
Annals of Emergency Medicine. 2024-10-01 - 1 citationsIdentification and definition of type 2 myocardial infarction: Where do we go from here?James McCord
International Journal of Cardiology. 2024-06-15
Press Mentions
- Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus VaccinesNovember 1st, 2022
- ACC Advocacy: Engage, Influence, AdvocateOctober 13th, 2022
- Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir in Patients with COVID-19: JACC Review Topic of the WeekOctober 12th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: